Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bilastine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bilastine 20mg tablets
0304010AFAAAAAA
|
Bilastine | Bilastine | Respiratory System | 1,144 |
|
Ilaxten 20mg tablets
0304010AFBBAAAA
|
Ilaxten | Bilastine | Respiratory System | 23 |
|
Bilastine 10mg orodispersible tablets sugar free
0304010AFAAACAC
|
Bilastine | Bilastine | Respiratory System | 19 |
|
Bilastine 2.5mg/ml oral solution sugar free
0304010AFAAABAB
|
Bilastine | Bilastine | Respiratory System | No data available |
|
Ilaxten 10mg orodispersible tablets
0304010AFBBACAC
|
Ilaxten | Bilastine | Respiratory System | No data available |
|
Ilaxten 2.5mg/ml oral solution
0304010AFBBABAB
|
Ilaxten | Bilastine | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.